Sign In
Buy RBOT
$0.0762
-0.0057 (-7.01%)
At Close: Jul 31, 2026
Vicarious Surgical Announces Reverse Stock Split
04:15pm, Monday, 10'th Jun 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives t
RBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024
08:54pm, Monday, 29'th Apr 2024
Vicarious Surgical (NYSE: RBOT ) just reported results for the first quarter of 2024. Vicarious Surgical reported earnings per share of -9 cents.
Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
08:16pm, Monday, 29'th Apr 2024
Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - Head, Investor Relations Adam Sachs - Co-Founder and CEO Bill Kell
Vicarious Surgical Reports First Quarter 2024 Financial Results
04:05pm, Monday, 29'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives t
Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024
04:30pm, Monday, 08'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficien
Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript
05:32pm, Monday, 04'th Mar 2024
Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participant
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
04:10pm, Monday, 04'th Mar 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient
Vicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare Conference
08:30am, Tuesday, 20'th Feb 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient
Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
04:30pm, Monday, 12'th Feb 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficien
Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President
08:30am, Monday, 29'th Jan 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient
Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference
08:30am, Wednesday, 15'th Nov 2023
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient
Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript
08:05pm, Monday, 13'th Nov 2023
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Ke
Vicarious Surgical Reports Third Quarter 2023 Financial Results
04:05pm, Monday, 13'th Nov 2023
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient
Vicarious Surgical to Report Third Quarter 2023 Financial Results on November 13, 2023
09:00am, Thursday, 26'th Oct 2023
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficien
Vicarious Surgical Receives Continued Listing Standard Notice From NYSE
05:00pm, Friday, 22'nd Sep 2023
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient
